I. Paradis, BRONCHIOLITIS OBLITERANS - PATHOGENESIS, PREVENTION, AND MANAGEMENT, The American journal of the medical sciences, 315(3), 1998, pp. 161-178
Increasing early success-post lung transplant has been tempered by the
longterm development of histologic bronchiolitis obliterans (OB) or o
f the progressive airway obstruction which is called bronchiolitis obl
iterans syndrome (BOS). Multiple lines of evidence suggest that OB/BOS
is due to an injury directed against the epithelial cells in the airw
ays of the donor lung by the immune system of the recipient. Acute rej
ection is the strongest risk factor for the subsequent development of
this process. Efforts to prevent or minimize acute rejection may reduc
e the prevalence of OB/BOS. Results of treatment with augmented immuno
suppression have been disappointing but the treatment of complicating
infections in the allograft can be beneficial. Multicenter studies are
needed to assess the efficacy of new immunosuppressive agents in prev
enting or treating OB/BOS.